Kintara Therapeutics Granted Fast Track Designation from the FDA for VAL-083 for Newly-Diagnosed Glioblastoma Read more
Boehringer Ingelheim and CarthroniX announce partnership to pursue small molecule therapeutics in canine oncology Read more
Pfizer, MorphoSys and Incyte Enter into Clinical Trial Collaboration for Monjuvi (tafasitamab-cxix) in Combination with TTI-622, a Fusion Protein Directed Against CD47 Read more
Amylyx Pharmaceuticals Announces Health Canada Approval of ALBRIOZA for the Treatment of ALS Read more
Oxford BioTherapeutics Announces Research Collaboration with ImmunoGen to Develop Novel Antibody-Drug Conjugates Read more